Wilson ' s disease : Early Diagnostic Value of Serum Ceruloplasmin Level to Prevent Chronic Psychosis-Case Report

Wilson disease is a rare autosomal recessive hereditary disorder of copper metabolism. It is characterized by excessive deposition of copper in the liver, brain, and other tissues due to mutation in the Wilson disease protein (ATP7B) gene which leads to impaired copper metabolism. We report a case of eighteen-year-old male patient, who presented at the Out-Patient Department of Medicine Unit 1, Abbasi Shaheed Hospital. He presented with history of ataxia for 2 years along with abnormal spastic hand movements and difficulty in speech for the same time period. These symptoms remained static till 12 months but later progressed with multiple episodes of fall after which he was bedridden. On further investigation, eye examination on slit lamp showed Kayser-Fleischer ring, low total leukocyte count and ceruloplasmin level of 0.03 g/L. Ultrasound results showed hyperechoic hepatic parenchyma with no mass or abscess. This case is notable to emphasize the diagnostic value of ceruloplasmin for early diagnosis and to prevent chronic psychosis along with neurological symptoms. We aim to review the clinical presentation, diagnostic modalities and current treatment and also to highlight the treatment trials underway for Wilsons disease in adult patients.

[1]  H. Yoo,et al.  Diagnostic Value of Ceruloplasmin in the Diagnosis of Pediatric Wilson's Disease , 2015, Pediatric gastroenterology, hepatology & nutrition.

[2]  A. Findeisen,et al.  Morbus Wilson: Case report of a two-year-old child as first manifestation , 2006, Scandinavian journal of gastroenterology.

[3]  J. Borjigin,et al.  Wilson disease in septuagenarian siblings: Raising the bar for diagnosis , 2005, Hepatology.

[4]  R. Klausner,et al.  Biochemical Characterization of the Wilson Disease Protein and Functional Expression in the Yeast Saccharomyces cerevisiae * , 1997, The Journal of Biological Chemistry.

[5]  J. Jankovic,et al.  Neurologic presentation of Wilson disease without Kayser-Fleischer rings , 1996, Neurology.

[6]  T. Sugiyama,et al.  Copper incorporation into ceruloplasmin in rat livers. , 1995, Biochimica et biophysica acta.

[7]  Anthony E. Lang,et al.  Movement Disorders: A Comprehensive Survey , 1989 .

[8]  R. Pfeiffer Wilson's Disease. , 1988, Seminars in neurology.

[9]  R. Wiesner,et al.  Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. , 1985, Gastroenterology.

[10]  A. Członkowska,et al.  [Wilson disease - factors affecting clinical presentation]. , 2013, Neurologia i Neurochirurgia Polska.

[11]  D. Eidelberg,et al.  Book Review Movement Disorders: Neurologic principles and practice Edited by Ray L. Watts and William C. Koller. 779 pp., illustrated. New York, McGraw-Hill, 1997. $125. 0-07-035203-8 , 1997 .

[12]  M. Akil,et al.  Psychiatric and behavioral abnormalities in Wilson's disease. , 1995, Advances in neurology.

[13]  R. Steinert,et al.  Pseudo-Kayser-Fleischer ring of the cornea associated with non-Wilsonian liver disease. A case report and literature review. , 1993, Cornea.

[14]  S. Bellary,et al.  Wilson's disease: a diagnosis made in two individuals greater than 40 years of age. , 1993, The Journal of the Oklahoma State Medical Association.